3-Methyl-2-oxovaleric acid (sodium)

3-Methyl-2-oxovaleric acid sodium is a degradation product from Isoleucine. 3-Methyl-2-oxovaleric acid sodium is a biomarker of mustard airway diseases (MADs) and uric acid stone[1][2].

Product Specifications

CAS Number

[3715-31-9]

UNSPSC

12352200

Hazard Statement

H302, H315, H319, H335

Target

Endogenous Metabolite

Type

Biochemical Assay Reagents

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/3-methyl-2-oxovaleric-acid-sodium.html

Purity

99.60

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

CCC(C(C(O[Na])=O)=O)C

Molecular Formula

C6H9NaO3

Molecular Weight

152.12

Precautions

H302, H315, H319, H335

References & Citations

[1]Ghoochani BFNM, et, al. Metabolomics diagnostic approach to mustard airway diseases: a preliminary study. Iran J Basic Med Sci. 2018 Jan;21 (1) :59-69.|[2]Xu S, et al. Self-control study of multi-omics in identification of microenvironment characteristics in urine of uric acid stone. Sci Rep. 2024 Oct 24;14 (1) :25165.